Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease
- 1 August 2000
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 402 (1-2) , 1-10
- https://doi.org/10.1016/s0014-2999(00)00440-4
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- The response of human platelets to activated components of the complement systemImmunology Today, 1991
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Fibrin formation and platelet aggregation in patients with acute myocardial infarction: Effects of intravenous and subcutaneous low-dose heparinAmerican Heart Journal, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985
- Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.Circulation, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- A Controlled Comparison of Aspirin and Oral Anticoagulants in Prevention of Death after Myocardial InfarctionNew England Journal of Medicine, 1982
- Incidence of Left-Ventricular Thrombosis after Acute Transmural Myocardial InfarctionNew England Journal of Medicine, 1981
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980